129 related articles for article (PubMed ID: 37310574)
21. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MC; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE; Waber DP
Pediatr Blood Cancer; 2011 Sep; 57(3):492-8. PubMed ID: 21560226
[TBL] [Abstract][Full Text] [Related]
22. A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children.
Fan DS; Ng JS; Lam DS
Ophthalmology; 2001 Nov; 108(11):1973-7. PubMed ID: 11713064
[TBL] [Abstract][Full Text] [Related]
23. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
[TBL] [Abstract][Full Text] [Related]
24. Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease.
Tripathi RC; Kipp MA; Tripathi BJ; Kirschner BS; Borisuth NS; Shevell SK; Ernest JT
Lens Eye Toxic Res; 1992; 9(3-4):469-82. PubMed ID: 1301798
[TBL] [Abstract][Full Text] [Related]
25. Steroid-induced ocular hypertension in normal cattle.
Gerometta R; Podos SM; Candia OA; Wu B; Malgor LA; Mittag T; Danias J
Arch Ophthalmol; 2004 Oct; 122(10):1492-7. PubMed ID: 15477461
[TBL] [Abstract][Full Text] [Related]
26. INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS.
Srinivasan R; Sharma U; George R; Raman R; Sharma T;
Retina; 2019 Jan; 39(1):157-162. PubMed ID: 29095355
[TBL] [Abstract][Full Text] [Related]
27. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
29. Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
Erdurmus M; Cohen EJ; Yildiz EH; Hammersmith KM; Laibson PR; Varssano D; Rapuano CJ
Cornea; 2009 Aug; 28(7):759-64. PubMed ID: 19574912
[TBL] [Abstract][Full Text] [Related]
30. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
31. Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation.
Raj A; Salvador-Culla B; Anwar H; Sykakis E; Figueiredo MS; Figueiredo FC
Cornea; 2020 Jan; 39(1):45-51. PubMed ID: 31517723
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Bhattacherjee P; Paterson CA; Spellman JM; Graff G; Yanni JM
Arch Ophthalmol; 1999 Mar; 117(3):361-4. PubMed ID: 10088814
[TBL] [Abstract][Full Text] [Related]
33. Ocular hypertensive response to topical dexamethasone ointment in children.
Lee YJ; Park CY; Woo KI
Korean J Ophthalmol; 2006 Sep; 20(3):166-70. PubMed ID: 17004631
[TBL] [Abstract][Full Text] [Related]
34. Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population.
Choi W; Bae HW; Choi EY; Kim M; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2020 Oct; 104(10):1423-1429. PubMed ID: 32071035
[TBL] [Abstract][Full Text] [Related]
35. Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids.
Shrestha S; Thapa M; Shah DN
Ocul Immunol Inflamm; 2014 Apr; 22(2):110-5. PubMed ID: 24131295
[TBL] [Abstract][Full Text] [Related]
36. A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study.
Moss EB; Buys YM; Low SA; Yuen D; Jin YP; Chapman KR; Trope GE
J Glaucoma; 2017 Feb; 26(2):182-186. PubMed ID: 27096722
[TBL] [Abstract][Full Text] [Related]
37. Increased intraocular pressure during treatment for chronic uveitis.
BenEzra D; Wysenbeek YS; Cohen E
Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):200-3. PubMed ID: 9143886
[TBL] [Abstract][Full Text] [Related]
38. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Nazm N; Dubey S; Gandhi M; Pegu J
Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
[No Abstract] [Full Text] [Related]
39. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.
Medeiros FA; Weinreb RN; Zangwill LM; Alencar LM; Sample PA; Vasile C; Bowd C
Ophthalmology; 2008 Jun; 115(6):934-40. PubMed ID: 17936908
[TBL] [Abstract][Full Text] [Related]
40. Steroid-Induced Ocular Hypertension in a Pediatric Patient with Acute Lymphoblastic Leukemia: A Case Report.
Lai HY; Lai IC; Fang PC; Hsiao CC; Hsiao YT
Children (Basel); 2022 Mar; 9(3):. PubMed ID: 35327812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
